Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
23.85
USD
|
+0.72%
|
|
+0.34%
|
+3.07%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,933
|
4,383
|
6,009
|
4,404
|
5,589
|
5,773
|
-
|
-
|
Enterprise Value (EV)
1 |
4,264
|
5,607
|
7,586
|
6,033
|
7,249
|
7,305
|
7,324
|
7,295
|
P/E ratio
|
33.4
x
|
59.1
x
|
29.6
x
|
23.9
x
|
47.2
x
|
29.9
x
|
25.6
x
|
21.5
x
|
Yield
|
-
|
0.28%
|
1.03%
|
1.76%
|
-
|
1.4%
|
1.49%
|
1.51%
|
Capitalization / Revenue
|
1.6
x
|
2.36
x
|
2.5
x
|
1.73
x
|
2.4
x
|
2.37
x
|
2.25
x
|
2.14
x
|
EV / Revenue
|
2.32
x
|
3.02
x
|
3.16
x
|
2.37
x
|
3.11
x
|
3
x
|
2.86
x
|
2.71
x
|
EV / EBITDA
|
10.2
x
|
13.3
x
|
14.5
x
|
11.5
x
|
15
x
|
13.9
x
|
12.9
x
|
11.7
x
|
EV / FCF
|
-
|
-
|
27.1
x
|
24.3
x
|
25.7
x
|
24.4
x
|
22
x
|
19.5
x
|
FCF Yield
|
-
|
-
|
3.69%
|
4.11%
|
3.89%
|
4.09%
|
4.55%
|
5.14%
|
Price to Book
|
1.32
x
|
1.89
x
|
2.41
x
|
1.88
x
|
2.4
x
|
2.27
x
|
2.19
x
|
2.08
x
|
Nbr of stocks (in thousands)
|
251,099
|
247,213
|
247,503
|
242,086
|
241,516
|
242,064
|
-
|
-
|
Reference price
2 |
11.68
|
17.73
|
24.28
|
18.19
|
23.14
|
23.85
|
23.85
|
23.85
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,836
|
1,854
|
2,400
|
2,549
|
2,333
|
2,439
|
2,563
|
2,695
|
EBITDA
1 |
416.7
|
422.6
|
524.9
|
526.6
|
482.3
|
525.5
|
568.4
|
623.9
|
EBIT
1 |
262
|
380.4
|
485.2
|
485
|
315.6
|
482.6
|
528.3
|
573.6
|
Operating Margin
|
14.27%
|
20.52%
|
20.22%
|
19.02%
|
13.53%
|
19.79%
|
20.61%
|
21.28%
|
Earnings before Tax (EBT)
1 |
140.9
|
81.1
|
251.7
|
272
|
129.1
|
286
|
327
|
350
|
Net income
1 |
92.2
|
75.7
|
203.3
|
187.2
|
118.1
|
215.1
|
250.9
|
268
|
Net margin
|
5.02%
|
4.08%
|
8.47%
|
7.34%
|
5.06%
|
8.82%
|
9.79%
|
9.94%
|
EPS
2 |
0.3500
|
0.3000
|
0.8200
|
0.7600
|
0.4900
|
0.7967
|
0.9300
|
1.110
|
Free Cash Flow
1 |
-
|
-
|
279.7
|
248.1
|
282.3
|
299
|
333.4
|
374.8
|
FCF margin
|
-
|
-
|
11.66%
|
9.73%
|
12.1%
|
12.26%
|
13.01%
|
13.91%
|
FCF Conversion (EBITDA)
|
-
|
-
|
53.29%
|
47.11%
|
58.53%
|
56.89%
|
58.66%
|
60.09%
|
FCF Conversion (Net income)
|
-
|
-
|
137.58%
|
132.53%
|
239.03%
|
139.01%
|
132.9%
|
139.87%
|
Dividend per Share
2 |
-
|
0.0500
|
0.2500
|
0.3200
|
-
|
0.3349
|
0.3552
|
0.3600
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
616.2
|
646.9
|
680.2
|
676.9
|
618.5
|
573.8
|
574.4
|
586.1
|
599.3
|
573.4
|
588.4
|
608.9
|
633.8
|
610.9
|
614.2
|
EBITDA
1 |
131.5
|
122.4
|
144.8
|
140.4
|
133.5
|
107.9
|
112.3
|
116.1
|
134.1
|
119.8
|
122.7
|
128.4
|
141
|
132.6
|
134.2
|
EBIT
1 |
121.9
|
111.4
|
134.2
|
130.1
|
122.9
|
97.8
|
102.8
|
106
|
122.3
|
77.8
|
112.3
|
118.1
|
130.4
|
122.2
|
122.2
|
Operating Margin
|
19.78%
|
17.22%
|
19.73%
|
19.22%
|
19.87%
|
17.04%
|
17.9%
|
18.09%
|
20.41%
|
13.57%
|
19.08%
|
19.39%
|
20.57%
|
20%
|
19.9%
|
Earnings before Tax (EBT)
|
53.2
|
37.9
|
76.4
|
87.5
|
69.8
|
38.3
|
59.9
|
48
|
-16.4
|
37.6
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
36
|
3.9
|
56.1
|
63.6
|
53.2
|
12.7
|
42.9
|
29.9
|
-31.8
|
77.1
|
48.1
|
51.9
|
62.4
|
52.8
|
58.4
|
Net margin
|
5.84%
|
0.6%
|
8.25%
|
9.4%
|
8.6%
|
2.21%
|
7.47%
|
5.1%
|
-5.31%
|
13.45%
|
8.18%
|
8.52%
|
9.84%
|
8.64%
|
9.51%
|
EPS
2 |
0.1500
|
0.0100
|
0.2300
|
0.2500
|
0.2200
|
0.0500
|
0.1800
|
0.1200
|
-0.1300
|
0.3200
|
0.1600
|
0.1750
|
0.2300
|
0.1900
|
0.2400
|
Dividend per Share
2 |
0.0600
|
0.0800
|
0.0800
|
0.0800
|
0.0800
|
0.0800
|
0.0800
|
-
|
0.0800
|
-
|
0.0800
|
0.0800
|
0.0800
|
0.0900
|
-
|
Announcement Date
|
10/27/21
|
2/22/22
|
4/27/22
|
7/27/22
|
10/26/22
|
2/21/23
|
4/26/23
|
7/26/23
|
10/25/23
|
2/20/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,331
|
1,224
|
1,577
|
1,630
|
1,661
|
1,532
|
1,551
|
1,522
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.194
x
|
2.895
x
|
3.004
x
|
3.095
x
|
3.443
x
|
2.914
x
|
2.729
x
|
2.44
x
|
Free Cash Flow
1 |
-
|
-
|
280
|
248
|
282
|
299
|
333
|
375
|
ROE (net income / shareholders' equity)
|
10.5%
|
10.6%
|
14.4%
|
14.5%
|
13.4%
|
14.4%
|
14.8%
|
15.5%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
7.21%
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
2,820
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
8.880
|
9.390
|
10.10
|
9.690
|
9.640
|
10.50
|
10.90
|
11.50
|
Cash Flow per Share
2 |
0.6600
|
1.050
|
1.320
|
1.200
|
1.380
|
1.320
|
1.330
|
-
|
Capex
1 |
29.7
|
28.8
|
46.3
|
47.8
|
52.7
|
60
|
55.7
|
58.7
|
Capex / Sales
|
1.62%
|
1.55%
|
1.93%
|
1.87%
|
2.26%
|
2.46%
|
2.17%
|
2.18%
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
23.85
USD Average target price
27.51
USD Spread / Average Target +15.35% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.07% | 5.77B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|